Interparfums (IPAR) Competitors

Coty presently has a consensus target price of $3.35, suggesting a potential upside of 21.03%. Interparfums has a consensus target price of $123.29, suggesting a potential upside of 6.34%. Given Coty's higher probable upside, equities analysts clearly believe Coty is more favorable than Interparfums.

Coty has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market.

Interparfums has a net margin of 11.17% compared to Coty's net margin of -9.20%. Interparfums' return on equity of 15.21% beat Coty's return on equity.

In the previous week, Coty had 16 more articles in the media than Interparfums. MarketBeat recorded 22 mentions for Coty and 6 mentions for Interparfums. Interparfums' average media sentiment score of 0.36 beat Coty's score of 0.34 indicating that Interparfums is being referred to more favorably in the news media.

Interparfums has lower revenue, but higher earnings than Coty. Coty is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

42.4% of Coty shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 5.9% of Coty shares are held by company insiders. Comparatively, 43.6% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

e.l.f. Beauty has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, Interparfums has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

e.l.f. Beauty presently has a consensus target price of $91.31, indicating a potential downside of 10.07%. Interparfums has a consensus target price of $123.29, indicating a potential upside of 6.34%. Given Interparfums' higher possible upside, analysts clearly believe Interparfums is more favorable than e.l.f. Beauty.

92.4% of e.l.f. Beauty shares are held by institutional investors. Comparatively, 55.6% of Interparfums shares are held by institutional investors. 3.5% of e.l.f. Beauty shares are held by company insiders. Comparatively, 43.6% of Interparfums shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Interparfums has lower revenue, but higher earnings than e.l.f. Beauty. Interparfums is trading at a lower price-to-earnings ratio than e.l.f. Beauty, indicating that it is currently the more affordable of the two stocks.

In the previous week, e.l.f. Beauty had 10 more articles in the media than Interparfums. MarketBeat recorded 16 mentions for e.l.f. Beauty and 6 mentions for Interparfums. e.l.f. Beauty's average media sentiment score of 1.28 beat Interparfums' score of 0.36 indicating that e.l.f. Beauty is being referred to more favorably in the media.

Interparfums has a net margin of 11.17% compared to e.l.f. Beauty's net margin of 3.38%. Interparfums' return on equity of 15.21% beat e.l.f. Beauty's return on equity.

Lamb Weston has higher revenue and earnings than Interparfums. Interparfums is trading at a lower price-to-earnings ratio than Lamb Weston, indicating that it is currently the more affordable of the two stocks.

Interparfums has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Lamb Weston has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market.

In the previous week, Interparfums had 2 more articles in the media than Lamb Weston. MarketBeat recorded 6 mentions for Interparfums and 4 mentions for Lamb Weston. Lamb Weston's average media sentiment score of 1.25 beat Interparfums' score of 0.36 indicating that Lamb Weston is being referred to more favorably in the news media.

55.6% of Interparfums shares are held by institutional investors. Comparatively, 89.6% of Lamb Weston shares are held by institutional investors. 43.6% of Interparfums shares are held by insiders. Comparatively, 1.0% of Lamb Weston shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Interparfums has a net margin of 11.17% compared to Lamb Weston's net margin of 4.39%. Lamb Weston's return on equity of 23.33% beat Interparfums' return on equity.

Interparfums currently has a consensus target price of $123.29, indicating a potential upside of 6.34%. Lamb Weston has a consensus target price of $53.36, indicating a potential downside of 1.42%. Given Interparfums' stronger consensus rating and higher possible upside, equities analysts clearly believe Interparfums is more favorable than Lamb Weston.

Interparfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.8%. Lamb Weston pays an annual dividend of $1.52 per share and has a dividend yield of 2.8%. Interparfums pays out 61.2% of its earnings in the form of a dividend. Lamb Weston pays out 73.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Interparfums has raised its dividend for 4 consecutive years and Lamb Weston has raised its dividend for 7 consecutive years. Lamb Weston is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Interparfums has a net margin of 11.17% compared to Medifast's net margin of -8.08%. Interparfums' return on equity of 15.21% beat Medifast's return on equity.

Medifast currently has a consensus price target of $12.00, suggesting a potential upside of 4.26%. Interparfums has a consensus price target of $123.29, suggesting a potential upside of 6.34%. Given Interparfums' stronger consensus rating and higher possible upside, analysts plainly believe Interparfums is more favorable than Medifast.

Interparfums has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

95.5% of Medifast shares are owned by institutional investors. Comparatively, 55.6% of Interparfums shares are owned by institutional investors. 3.7% of Medifast shares are owned by insiders. Comparatively, 43.6% of Interparfums shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Medifast has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market. Comparatively, Interparfums has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market.

In the previous week, Interparfums had 6 more articles in the media than Medifast. MarketBeat recorded 6 mentions for Interparfums and 0 mentions for Medifast. Interparfums' average media sentiment score of 0.36 beat Medifast's score of -1.27 indicating that Interparfums is being referred to more favorably in the news media.